The Food and Drug Administration (FDA) has ordered the recall of two batches of a medication used to treat hypothyroidism, after stability tests found its active ingredient levels had fallen below standard, potentially reducing the drug's effectiveness, an FDA official said today.
The recall covers batches D2402370 and D2402371 of Thyrocure 50mcg, totaling more than 1.12 million tablets manufactured by Biofrontier Inc, Asia.
The medication's main active ingredient, levothyroxine sodium, is used to treat hypothyroidism, or underactive thyroid, the FDA said.
Photo taken from Food and Drug Administration package insert electronic system
FDA official Yang Po-wen (楊博文) said that the company voluntarily notified the agency on Sept. 30 after three-month stability tests showed the active ingredient content had fallen below the required specification limit, possibly reducing the drug's effectiveness.
The FDA has instructed the company to complete the recall by Nov. 3, Yang said.
A total of 1,123,000 tablets from the affected batches have been distributed, while 1,175,760 tablets remain in stock — enough for about 49 months of domestic supply, Yang added.
The company also plans to import another 500,000 tablets, or about 21 months of supply, in the first quarter of next year.
Taiwan has received more than US$70 million in royalties as of the end of last year from developing the F-16V jet as countries worldwide purchase or upgrade to this popular model, government and military officials said on Saturday. Taiwan funded the development of the F-16V jet and ended up the sole investor as other countries withdrew from the program. Now the F-16V is increasingly popular and countries must pay Taiwan a percentage in royalties when they purchase new F-16V aircraft or upgrade older F-16 models. The next five years are expected to be the peak for these royalties, with Taiwan potentially earning
STAY IN YOUR LANE: As the US and Israel attack Iran, the ministry has warned China not to overstep by including Taiwanese citizens in its evacuation orders The Ministry of Foreign Affairs (MOFA) yesterday rebuked a statement by China’s embassy in Israel that it would evacuate Taiwanese holders of Chinese travel documents from Israel amid the latter’s escalating conflict with Iran. Tensions have risen across the Middle East in the wake of US and Israeli airstrikes on Iran beginning Saturday. China subsequently issued an evacuation notice for its citizens. In a news release, the Chinese embassy in Israel said holders of “Taiwan compatriot permits (台胞證)” issued to Taiwanese nationals by Chinese authorities for travel to China — could register for evacuation to Egypt. In Taipei, the ministry yesterday said Taiwan
‘LIKE-MINDED PARTNER’: Tako van Popta said it would be inappropriate to delay signing the deal with Taiwan because of China, adding he would promote the issue Canadian senators have stressed Taiwan’s importance for international trade and expressed enthusiasm for ensuring the Taiwan-Canada trade cooperation framework agreement is implemented this year. Representative to Canada Harry Tseng (曾厚仁) in an interview with the Central News Agency (CNA) said he was increasingly uneasy about Ottawa’s delays in signing the agreement, especially as Ottawa has warmed toward Beijing. There are “no negotiations left. Not only [is it] initialed, we have three versions of the text ready: English, French and Mandarin,” Tseng said. “That tells you how close we are to the final signature.” Tseng said that he hoped Canadian Prime Minister Mark Carney
Taiwan is awaiting official notification from the US regarding the status of the Agreement on Reciprocal Trade (ART) after the US Supreme Court ruled US President Donald Trump's global tariffs unconstitutional. Speaking to reporters before a legislative hearing today, Premier Cho Jung-tai (卓榮泰) said that Taiwan's negotiation team remains focused on ensuring that the bilateral trade deal remains intact despite the legal challenge to Trump's tariff policy. "The US has pledged to notify its trade partners once the subsequent administrative and legal processes are finalized, and that certainly includes Taiwan," Cho said when asked about opposition parties’ doubts that the ART was